Veradigm announces initial financial guidance for fiscal 2024

Chicago--(business wire)-- #healthit--veradigm inc. (otcmkts: mdrx), a leading provider of healthcare data and technology solutions, announced today it has reaffirmed the estimated, unaudited ranges for fiscal 2023 of gaap revenue, adjusted ebitda, and non-gaap diluted earnings per share that it provided on january 10, 2024, in the company's form 8-k filed on january 10, 2024, and initially reaffirmed on february 27, 2024. the company also introduced initial financial guidance for fiscal 2024 as follows: r.
MDRX Ratings Summary
MDRX Quant Ranking